1. Drug Enforcement Administration, Department of Justice (2005) Schedules of controlled substances: placement of pregabalin into schedule V. Fed Regist 70(144):43633–43635
2. European Medicines Agency (EMA). Lyrica – Procedural steps taken after authorisation. Available from: www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Procedural_steps_taken_and_scientific_information_after_authorisation/human/000546/WC500046604.pdf . Accessed 26th August 2010.
3. Schwan S, Sundström A, Stjernberg E, Hallberg E, Hallberg P (2010) A signal for abuse potential for pregabalin – results from the Swedish spontaneous adverse reaction reporting system. Eur J Clin Pharmacol 66:947–953
4. Caster O, Kindlundh-Högberg A, Hopstadius J, Norén GN (2010) Early indicators of drug dependence. Pharmacoepidem Dr S 19(S1):S224–S225